COGTNasdaqSEC EDGAREDGAR

Cogent Biosciences, Inc.

Pharmaceutical Preparations·WALTHAM, MA·FY end 12/31·CIK 1622229

Board of Directors

1 members · FY 2025
DirectorRoleTenureAgeCommitteesIndep.Annual fees
Andrew RobbinsCEO and Director50

Risk-factor diff

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Policies & disclosures

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.